EVP for Emerging Products Patrick Burke notes that our research and development model requires us to rely on collaborations with academics and pharmaceutical companies to help find answers to pressing medical questions.

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.